Yuri Lab-as-a-Service

Yuri is a leading commercial space biotech company that leverages the unique conditions of microgravity to research and develop groundbreaking biotechnological innovations and providing the implementation services (Yuri Lab-as-a-Service). With over 25 successful research missions to the ISS and partnerships with NASA, ESA, GSK, Charité Berlin, and MIT, our interdisciplinary team of aerospace engineers and biologists is taking pharmaceutical and bio­tech research to a new level – advancing drug discovery, optimized biomaterials, and sustainable food production processes both in space and on Earth. To achieve these goals Yuri manufactures space-based multi-user research, production and fabrication facilities for commercial biotechnology and pharma companies as well as international space agencies. Together with its partners, Yuri builds up the future commercial in-space life-science infrastructure.

Objectives and Mission

Our mission is to create innovative solutions for hu­man health through biotechnological research in space. We strive to develop new drugs, therapies, and technologies that benefit billions of people on Earth. By leveraging microgravity, we push the boun­daries of research and pave the way for a sustainable future in biotechnology.

Significant Achievements

Yuri has established itself as a key player in space biotechnology, with over 151 of our products successfully deployed in space. We serve a global client base of more than 60 organizations across 25 countries, including prestigious partners such as NASA, ESA, DLR, MIT, Charité Berlin, and GSK. Building on insights from our space missions, we have developed an innovative biotech product line grounded in microgravity research. To date, our commercial success is reflected in over 10 million euros in revenue from completed contracts.

Get in Touch

For more information – contact@yurigravity.com

Relevant documents